Shenzhen Xuanxin Technology Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Xuanxin Technology Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ORLIVER. The owner is based in Shenzhen, Guangdong.

Longgang Street, Longgang District

Shenzhen, Guangdong 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ORLIVER
ORLIVER
Registered 2023

Trademark Classifications

Shenzhen Xuanxin Technology Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Xuanxin Technology Trading Co., Ltd. have?

Shenzhen Xuanxin Technology Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Xuanxin Technology Trading Co., Ltd. file in?

Shenzhen Xuanxin Technology Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Xuanxin Technology Trading Co., Ltd.'s most well-known trademarks?

Shenzhen Xuanxin Technology Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as ORLIVER. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Xuanxin Technology Trading Co., Ltd.'s trademark registration success rate?

Shenzhen Xuanxin Technology Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.